p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
about
Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
P2860
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@en
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@nl
type
label
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@en
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@nl
prefLabel
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@en
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
p53-/- synergizes with enhance ...... ors in acute myeloid leukemia.
@en
P2093
Adhithi Rajagopalan
Bhavana Bhatnagar
David M Lucas
David Yang
Emery H Bresnick
Eric Padron
Erik A Ranheim
Guangyao Kong
Jing Zhang
Jingfang Zhang
P2860
P304
P356
10.1182/BLOOD-2016-06-719237
P407
P577
2016-11-04T00:00:00Z